NCT04959188View on ClinicalTrials.gov

Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)

CompletedOBSERVATIONAL

Enrollment

53

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions

Dyskeratosis CongenitaTelomere Biology Disorders

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH